FDA Authorizes Second COVID Booster Shot For Those Age 50 and Older

Share, email, print, bookmark SOURCE reports.

WASHINGTON DC – The U.S. Food & Drug Administration authorized today, March 29 a second booster shot of the Pfizer and Moderna COVID-19 vaccines for every one age 50 and older or anyone who is immunocompromised.

Individuals are eligible four months after their first booster shot.

Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention is expected to release a statement on more details later today, March 29.

The decision comes as evidence increases that protection from three shots is fading and a fourth shot would help boost immunity.

But some experts are worried that the BA.2, an even more contagious version of the omicron variant, could cause a surge in cases as immunity to the virus fades.

Today’s decision bypasses the independent panel of experts from both the FDA and the CDC, which have issued recommendations to the agencies throughout the pandemic on whether they should clear additional shots.

This is a breaking report and will be updated later.

editor

email: editor@FraminghamSource.com call or text at 508-315-7176


Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/framin10/public_html/wp-includes/functions.php on line 5279

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/framin10/public_html/wp-content/plugins/really-simple-ssl/class-mixed-content-fixer.php on line 107